New Delta-5-Desaturase Inhibitor Suppress Lung Cancer Progression: A Paradigm Shift on COX-2 Biology in Lung Cancer Treatment

被引：0
|
作者：
Pang, Lizhi [1 ]
Shah, Harshit [1 ]
Zhao, Pinjing [1 ]
Qian, Steven [1 ]
Sathish, Venkatachalem [1 ]
机构：
[1] North Dakota State Univ, Fargo, ND USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.09700
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] COX-2 BLOCKADE IMMUNOLOGICALLY SUPPRESSES BRAIN METASTASES OF LUNG CANCER
    Fujita, Mitsugu
    Zhang, Rong
    Nakata, Susumu
    Kuzushima, Kiyotaka
    NEURO-ONCOLOGY, 2012, 14 : 38 - 38
  • [32] Knocking Down Delta-5 Desaturase and Exploiting High Expression Level of COX-2 to Inhibit Cancer Migration and Invasion
    Yang, Xiaoyu
    Xu, Yi
    Miskimins, Keith W.
    Qian, Steven Y.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S133 - S133
  • [33] COX-2 blockade immunologically suppresses brain metastasis of lung cancer
    Fujita, Mitsugu
    Nakata, Susumu
    Okuda, Takeshi
    Kato, Amami
    Yoshie, Osamu
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Resistance of prostate cancer cell lines to COX-2 inhibitor treatment
    Wagner, M
    Loos, J
    Weksler, N
    Gantner, M
    Corless, CL
    Barry, JM
    Beer, TM
    Garzotto, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (03) : 800 - 807
  • [35] Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer
    Liao, ZX
    Milas, L
    Komaki, R
    Stevens, C
    Cox, JD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S85 - S91
  • [36] COX-2 immunoexpression in inflammatory breast cancer. A rationale base for a neoadjuvant treatment with COX-2 inhibitor
    Manfrin, Erminia
    Remo, Andrea
    Martignoni, Guido
    Brunelli, Matteo
    Reghellin, Daniela
    Dal Fior, Daniela
    Franceschetti, Ilaria
    Rapagnani, Maria Paola
    Parisi, Alice
    Menestrina, Fabio
    Bonetti, Franco
    MODERN PATHOLOGY, 2006, 19 : 16 - 16
  • [37] COX-2 - A new target for cancer prevention and treatment - Preface
    Dannenberg, AJ
    DuBois, RN
    COX-2: A NEW TARGET FOR CANCER PREVENTION AND TREATMENT, 2003, 37 : VII - VIII
  • [38] Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer
    Anagnostou, Valsamo K.
    Brahmer, Julie R.
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 976 - 984
  • [39] COX-2 inhibitors as cancer treatment: Will they be the new warfarin or trastuzumab?
    Liebmann, J
    CANCER INVESTIGATION, 2004, 22 (02) : 324 - 325
  • [40] Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer
    Cao, Chunxia
    Gao, Ruli
    Zhang, Min
    Amelio, Antonio L.
    Fallahi, Mohammad
    Chen, Zirong
    Gu, Yumei
    Hu, Chengbin
    Welsh, Eric A.
    Engel, Brienne E.
    Haura, Eric B.
    Cress, W. Douglas
    Wu, Lizi
    Zajac-Kaye, Maria
    Kaye, Frederic J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
12345